Why the study?
Oral anticoagulation with vitamin K antagonists prevents venous thromboembolism recurrence, but the quality of oral anticoagulation in regular medical care compared to a telemedicine-based coagulation service required investigation.
Does a telemedicine-based coagulation service improve clinical outcomes in patients with venous thromboembolism on vitamin K antagonists compared to regular medical care?
Population
360 patients with VTE from RMC and 254 from CS
Comparison
Telemedicine-based coagulation service vs regular medical care
Design
Prospective multi-center study
Authors
Loading...
Specialized CS was associated with higher TTR in VTE on VKA; leaves open whether RCTs confirm outcome benefits over RMC.
Does a telemedicine-based coagulation service improve clinical outcomes in patients with venous thromboembolism on vitamin K antagonists compared to regular medical care?
A telemedicine-based coagulation service significantly improves time in therapeutic range and reduces adverse clinical outcomes, including mortality and bleeding, in VTE patients on vitamin K antagonists compared to regular medical care.
Keller et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: